Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting. [electronic resource]
Producer: 20120629Description: 923-9 p. digitalISSN:- 1432-0584
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- analysis
- Benzamides
- Biomarkers, Pharmacological -- analysis
- Blood Chemical Analysis
- Clinical Laboratory Techniques
- Diagnostic Tests, Routine
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- blood
- Male
- Middle Aged
- Piperazines -- analysis
- Predictive Value of Tests
- Prognosis
- Pyrimidines -- analysis
- Retrospective Studies
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.